M. Castrogago et al., SERUM CARNITINE LEVELS IN EPILEPTIC CHILDREN BEFORE AND DURING TREATMENT WITH VALPROIC ACID, CARBAMAZEPINE, AND PHENOBARBITAL, Journal of child neurology, 13(11), 1998, pp. 546-549
Serum levels of free, acyl, and total carnitine were determined in 32
patients with seizures, before and after 3, 6, and 12 months of treatm
ent with valproic acid (17 patients), carbamazepine (10 patients), or
phenobarbital (5 patients). In all three treated groups, both free and
total carnitine levels showed a significant decline with resp ect to
pretreatment levels. This decline was most marked and most consistent
in patients treated with valproic acid. In 35% of the patients in this
group, carnitine deficiency (ie, total carnitine < 30 mu mol/L) was o
bserved by month 12. In none of the three groups were serum carnitine
levels significantly correlated with the serum concentration of the dr
ug. These findings suggest a need to monitor serum carnitine levels in
children treated with any of these drugs.